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Cost-effective generation of precise 
label-free quantitative proteomes 
in high-throughput by microLC and 
data-independent acquisition
Jakob Vowinckel1,3, Aleksej Zelezniak1,4,5, Roland Bruderer3, Michael Mülleder1,2,  
Lukas Reiter3 & Markus Ralser  1,2
Quantitative proteomics is key for basic research, but needs improvements to satisfy an increasing 
demand for large sample series in diagnostics, academia and industry. A switch from nanoflowrate 
to microflowrate chromatography can improve throughput and reduce costs. However, concerns 
about undersampling and coverage have so far hampered its broad application. We used a QTOF mass 
spectrometer of the penultimate generation (TripleTOF5600), converted a nanoLC system into a 
microflow platform, and adapted a SWATH regime for large sample series by implementing retention 
time- and batch correction strategies. From 3 µg to 5 µg of unfractionated tryptic digests that are 
obtained from proteomics-typical amounts of starting material, microLC-SWATH-MS quantifies up 
to 4000 human or 1750 yeast proteins in an hour or less. In the acquisition of 750 yeast proteomes, 
retention times varied between 2% and 5%, and quantified the typical peptide with 5–8% signal 
variation in replicates, and below 20% in samples acquired over a five-months period. Providing 
precise quantities without being dependent on the latest hardware, our study demonstrates that 
the combination of microflow chromatography and data-independent acquisition strategies has 
the potential to overcome current bottlenecks in academia and industry, enabling the cost-effective 
generation of precise quantitative proteomes in large scale.
In basic biological and biomedical research, mass spectrometry-based proteomics has emerged as a prime tech-
nology for identifying and quantifying proteins, determining activity, turnover, modification state, and closing 
the gaps in structural biochemistry1–3. Proteomic technology has progressed to the extent that, for low sample 
numbers, a broad coverage of the proteome is achieved4,5.
However, the same proteomic technology is far less frequently applied for the analysis of large quantitative 
sample series. The throughput and robustness required to analyse hundreds of proteomes in one experiment has 
been achieved by a few laboratories worldwide, is however by no means standard. The acquistion of large num-
bers of proteomes is currently associated with high costs, driven to a considerable extent by instrument time. In 
this sense, proteomics lags behind the other ‘omic’ disciplines, i.e. genomics, transcriptomics and metabolomics, 
where the precise analysis of large and very large sample series has become more regularly achieved. Large and 
intrinsically comparable sample series are however increasingly demanded also from proteomic experiments. 
Such sample series are required for data driven biology, clinical research and for diagnostic applications6.
Techncially, some key objectives substantially differ between proteomic experiments that deal with small com-
pared to large sample series, and make it difficult to scale up any proteomic experiment. In small-scale exper-
iments the number of peptides quantified, or proteomic depth, is typically a key parameter to benchmark the 
success of a proteomic experiment. In large sample series however, the effects of measurement noise amplify, 
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batch effects become prevalent, and stochastic elements reduce the number of consistently quantifiable peptides. 
In large scale applications, the precision as to how well the identified peptides are quantifiable, is hence a key 
parameter. Difficulties in maintaining quantification precision when scaling up a quantitative proteomic exper-
iment have several sources. One of them is the typical proteomic nanolitre flow rate chromatography (nanoLC). 
While handling of the typical proteomic nanoflow chromatography has become simpler, it still requires expert 
knowledge to be maintained robustly. The low flow rate and small capillary diameters as required in nanoLC 
systems are susceptible to all sorts of technical distortions that regularly create major batch effects. Typical 
reversed-phase columns used in nanoLC need to be exchanged after a maximum of a few hundred injections, 
while the low flow rates render it a challenge to maintain an electrospray fully stable over long measurement peri-
ods. As a consequence, batch effects detected in large sample series are often stronger than the protein expression 
differences between the typical samples2,7.
Other constraints emerge from the situation that proteomes are complex by nature. This introduces stochastic 
elements through ‘undersampling’, when the acquisition speed of a mass spectrometer is slower than the number 
of co-eluting analytes. Undersampling reduces the number of consistently quantifiable peptides the more samples 
are measured. There are several developments to overcome undersampling. These include to computationally 
impute missing values or to record proteomes in a data-independent manner2,8,9. However, in the end it is physi-
cal limits that make the detection of every single peptide in every single sample a challenging task.
A decade of proteome research has revealed important molecular details about function and regulation of the 
proteome. This biological information can be exploited to tailor a new generation of proteomics workflows to 
obtain the maximum biological information despite technical limits. Most importantly, many proteomic exper-
iments have shown typical proteomic responses affecting dozens to hundreds of proteins in parallel, so that not 
all of them have to be quantified in order to detect a precise biological signature. This allows a substantial amount 
of biological information to be retrieved from just a subsets of proteins, sentinels or antibody-detectable protein 
markers, for instance10–12. However, a difficulty remains that the quantitative concentration changes detected on 
the proteome level, in relative terms, are often smaller than the ones detected at the transcriptome or metabolome 
level and, therefore, require more precise measurements13. For many new applications of proteomics, like the 
ones which concentrate on pattern detection and data-driven systems biology, the ultimate goal of achieving full 
proteome coverage has become less urgent compared to the rapidly increasing need for achieving high quanti-
tative precision that allows small concentration changes to be reliably detected across hundreds to thousands of 
samples. This demands workflows that are cost-effective, robust and easy to handle to the extent that they can be 
established by a large number of laboratories world-wide10,14–16.
Taking the advancements of proteomic technology and the main needs for data-driven biology into account, 
we combine several strategies to conceive a proteomic platform complementing other proteomic methods specif-
ically for the label-free protein quantification in large sample series. The platform combines microflow chroma-
tography, an analytical flow rate ion spray source (TurboV source, Sciex), data independent (SWATH) acquisition 
on a penultimate generation QqTOF instrument (TripleTOF5600, Sciex). We put particular emphasis and estab-
lished computational correction strategies for retention time shifts and non-linear batch effects that emerge in 
the same sample size. Furthermore, being able to determine the correlation of peptides across many samples, we 
exploit this information to improve the selection of quantifier peptides, typically conducted over abundance only. 
Even without being reliant on the newest or most expensive mass spectrometry nor LC hardware, we achieve the 
precise and consistent quantification of thousands of peptides across hundreds of proteomes. We report precision 
values consistently determined at large scale that are typically seen in highly controlled, small-scale proteomics 
experiments.
Results
Many of the key proteomic developments over the last decade have been concentrated on ion trap instruments 
due to their high sensitivity and resolution. However, due to their acquisition speed and high dynamic range, data 
independent acquisition workflows have been developed frequently on Quadrupole time of flight (qTOF) instru-
ments, and include the successful DIA workflows MSE17 and SWATH-MS18. Indeed, fast and increasingly sensitive 
qTOF instruments are available from multiple manufacturers and are popular in high-throughput laboratories 
due to their fast acquisition speed.
To be comparable with previous SWATH-MS developments, and to enable laboratories that have previously 
invested in DIA technology to implement our workflow, we use a conventionally sensitive, yet fast (100 HZ acqui-
sition) QqTOF mass spectrometer (TripleTOF 560019, SCIEX) on which the SWATH-MS acquisition method was 
originally developed18. The TripleTOF 5600 is not the newest and most sensitive mass spectrometer. Therefore, 
our study also serves as a benchmark as to what is realistically achievable without access to the newest and most 
expensive hardware. Not being dependent on the latest hardware can reduce costs and implementation burdens 
dramatically, and is important to enable broad access to large-scale, quantitative workflows. Along this line, in 
order to avoid specialist hardware dependency on the LC side, we combined this mass spectrometer with typical 
proteomic nanoLCs (NanoAquity, Waters, UK and nanoLC425, Eksigent, USA) that have been converted into 
microLCs through the exchange of capillaries (Waters) or flow modules (Eksigent). A further reduction of cost, 
and in parallel increased robustness, is also achieved through the use of microflow columns and analytical flow 
rate ionspray source. In our experience microflow columns block less frequently, and ideally last for years. On 
samples as prepared and analysed as in this study, a nanoLC column lasts typically up to 200 injections, while on 
a comparable set-up and samples, microLC columns last for about 3000 injections. (Please note that like in any 
chromatographic method, these values vary dependent on sample quality, LC method and hardware used). By 
reducing batch effects caused by exchange and/or blockage of columns, this situation reduces hands-on time (col-
umns need be exchanged less frequently and, therefore, the electrospray needs fewer readjustments), and reduces 
the costs incurred through column purchases by up to 90–95%.
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After having set-up the platform, we started with an evaluation of the relationship between sensitivity and flow 
rates on the combined nanoLC and microLC chromatographic set-up using the Eksigent LC by first operating 
the mass spectrometer, like in a conventional proteomic experiments, with a data-dependent acquisition (DDA) 
workflow. By varying flow rates from 300 nL/min to 10 µL/min, on 75 µm (0.3–0.7 µL/min) or 300 µm (1–10 µL/
min) inner diameter columns, we compared the signal intensities of spiked standardized peptides (iRT stand-
ards20) and the number of quantified proteins out of an unfractionated yeast whole proteome tryptic digest. While 
the 30-fold stepwise increase in flow rate reduced the total signal intensities by a factor of seven (Fig. 1A), it did 
not affect the number of detected proteins in yeast lysates with FDR cutoff <0.01 (Fig. 1B). Furthermore, while 
peak capacity decreased with increasing flow rates on the nanoflow setting, in microflow mode, chromatographic 
peak capacity increased with flow rate (Fig. 1C). A good compromise, considering total signal intensity, peak 
capacity and chromatographic quality was found at flow rates between 3 µL/min and 5 µL/min. While chromato-
graphic quality was stable at a broad range of flow rates (Fig. 1D), at 3 µL/min signal intensities were reduced only 
by a factor of 3.5 compared to nanoLC-MS/MS operating at 300 nL/min (Fig. 1A, dotted lines). Next, this moder-
ate decline in sensitivity could be compensated by exploiting the higher sample capacity of the microLC columns, 
which allow loading of up to 15 µg whole-proteome tryptic digest (up to 10× the amount that can be separated 
in nanoflow chromatography). In DDA mode, the analysis of an unfractionated yeast tryptic whole proteome 
digest led to the detection of >1200 proteins (1/4th of the yeast proteome) with as little as 2 µg unfractionated 
tryptic whole-proteome digest per single injection (Fig. 1E). Hence, microflow chromatography can be applied 
to quantitative proteomics without necessarily causing a substantial decline in protein identification numbers. A 
summary of all performed experiments, acquisition modes and settings is presented in Supplementary Table 1.
At this point it should be noted that, while more peptides are injected for microflow-chromatography, not 
more starting material is required for generating the samples. Due to handling difficulties (i.e. difficulties to filter 
and pH-adjust small volumes of liquid), typical proteomic sample preparation methods yield ~5–20 µL of tryptic 
digest. On nanoLC-MS/MS settings, 1 µL to 2 µL of the digest is typically injected, and 5–10 µL of the same digest 
is injected in the microLC setting. Thus, our microLC-based workflow does not require more input sample mate-
rial. Instead a lower amount of injection replicates can be run per sample. For most applications of quantitative 
proteomics however, multiple injection replicates are not required, as statistical methods require biological or 
at least full technical replicates. Injection replicates and are hence typically recorded only for method devel-
opment purposes or for the generation of spectral libraries, but not on large sample series. Indeed, in practice, 
microLC-based proteomics may be able to handle more diluted samples as derived from highly limiting starting 
material, for the simple reason a higher spectrum of injection volumes can be handled chromatographically.
We continued with an optimisation of the microflow chromatography, focussing on finding a good compro-
mise between number of identified analytes and gradient length for high throughput applications. While protein 
identification capacity increased with gradient length as expected, 30 minute microflow gradients were sufficient 
to identify >1000 yeast proteins (FDR <0.01) in a single injection of an unfractionated whole-proteome tryptic 
digest as analyzed by DDA (Fig. 1F). In combination with high pH reversed phase chromatography prefraction-
ation, the setup identified 3822 proteins, or 85% of all expressed yeast open reading frames as detected by GFP 
fusion and fluorescence microscopy21. Microflow-SWATH-MS is therefore competitive in regards to other pro-
teomic technologies that use nanoflow chromatography on instruments of a comparable generation22.
The 15% of non-detected proteins are, for the most part, proteins of low concentration, reflecting a 
proteomics-typical abundance bias (Fig. 1G). On a newer generation of ion trap mass spectrometers, yeast pro-
teomic depth did, upon extensive fractionation, go beyond these detection limits23. These results imply that the 
obtained protein number values are not yet exhausted and will increase when the workflow is optimized for 
increasing proteomic depth instead of sample numbers and robustness, or when using a more sensitive mass 
spectrometer (not the focus of this study).
Focussing on the chromatography, we obtained chromatographic peaks with an average full-width at half 
maximum (FWHM) of 12 seconds. While narrow peaks are generally desirable in chromatography, in proteom-
ics they amplify the problem of undersampling, a situation that emerges when more peptides elute at any unit in 
time than the mass spectrometer can process24. Data-independent acquisition (DIA) strategies, like SWATH-MS 
where all precursors falling into an isolation window are fragmented simultaneously and chromatograms are 
reconstructed computationally post-acquisition, have been designed to overcome this problem25. However, cycle 
times of conventional SWATH-MS were optimised for typical nanoLC-applications and are in the range of 3 sec-
onds. They would cover a 12 sec wide peak with only 4–6 data points, too little for accurate peak representation 
in precise quantification experiments (Fig. 1H). The SWATH regime was accelerated for 12 sec FWHM peaks by 
reducing the cycle time to 1.3 s. For this, the isolation window dwell time was reduced to to 40 ms, which did not 
cause a notable loss in signal intensity or number of peptide identifications (Suppl. Fig. 1). To further accelerate 
the acquisition cycle, we compromised and limited the segmented acquisition to record only the precursor-rich 
mass range between 400–850 m/z. This mass range covers 85% of precursors and enables the quantification of 
96% of proteins (Suppl. Fig. 2). Upon these modifications, our SWATH-MS method covered the typical microLC 
chromatographic peak with a critical number of 8–12 data points, yielding accurate peak representation for the 
application of fast chromatography (Fig. 1H).
Protein identification numbers and the quality of quantification are both dependent on the recorded data but 
also, specifically in DIA acquisition, on the spectral libraries used to extract the data. Therefore, we processed 
the datasets using different library generation strategies. SWATH libraries were generated in Spectronaut26 using 
proteome prefractionation (following standard approaches25,27), repeated injection of a sample mixture match-
ing the actual sample matrix (‘exhaustion’), or by pseudo-MS/MS correlative precursor-fragment feature extrac-
tion using DIA-Umpire28. The spectral libraries were generated following a previously optimized procedure27 at 
<1% FDR using a combination of X! Tandem29 and Comet30 search engines. The libraries were used to quantify 
peptides in an unfractionated, whole-cell Saccharomyces cerevisiae tryptic digest, of which 10 µg were separated 
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Figure 1. (A) Dependency of signal intensity on flow rate in a proteomic experiment. Combined intensities of 
standardized peptides (iRT) determined using nano, low-micro, and high-micro flow regimes on an Eksigent 
425 LC system equipped with three respective flow modules and recorded on a TripleTOF5600 mass 
spectrometer. Signal intensity is a function of the dilution rate, with a factor of 0.3 between 0.3 µL/min and 3 µL/
min. (B) Dependency of protein identifications on flow rate in a proteomic experiment. The number of 
detectable proteins by DDA were determined using nano, low-micro, and high-micro flow regimes on an 
Eksigent 425 LC system equipped with three respective flow modules and recorded on a TripleTOF5600 mass 
spectrometer. Number of identified proteins increased moderately with flow rate. (C) Peak capacities on a 
proteomic microLC set-up. Peak capacity was calculated from the measurement of standard peptides on the 
same chromatographic setup, varying the flow rate from 300 nL/min to 10 µL/min. Peak capacities of microLC 
increase with flow rate. (D) Peak characteristics on a proteomic microLC set-up. Average precursor peak shapes 
of 5 iRT peptides determined using flow rates of 1–10 µL/min on an Eksigent 3C18-CL-120 column. 
Chromatography is stable and reproducible in flow rates >1 µL/min. Shaded areas represent standard deviation 
of signal intensity. (E) 2 µg tryptic protein digest is sufficient to quantify >1200 yeast proteins in a single 
injection in microLC-SWATH-MS. Tryptic digests obtained from 1–15 µg of yeast whole proteome extracts33 
were injected and separated using a 60 min water to acetonitrile gradient at a flow-rate of 3 µL/min. 914 proteins 
were quantified with 1 µg, 1219 proteins with 2 µg, 1428 proteins with 5 µg and 1504 proteins with 15 µg digested 
protein. (F) A 30 min LC gradient is sufficient to quantify >1000 yeast proteins in a single injection in microLC-
SWATH-MS. A tryptic digest derived from 5 µg yeast protein was injected and separated using water-to-
acetonitrile chromatographic gradients of 10–90 min at a flow-rate of 3 µL/min. Extraction of the SWATH 
spectra yielded quantifiable peptides for 740 proteins (10 min), 946 proteins (20 min), 1170 proteins (30 min), 
1322 proteins (45 min), 1420 proteins (60 min) and 1455 proteins (90 min). SWATH-MS data was extracted in 
www.nature.com/scientificreports/
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on 60 min microLC gradients at a flow rate of 3 µL/min. By using the spectral library created by prefractiona-
tion, we quantified 1766 ± 46 yeast proteins using 34 × 25 m/z SWATH windows, or 1422 ± 53 proteins when 
using 29 × 16 m/z windows (Fig. 1H and Suppl. Fig. 3). The library generated by repeated injection of the same 
digest (exhaustion) yielded the quantification of 1271 ± 5 and 1157 ± 13 proteins, a similar performance com-
pared to data-extraction with a totally independently created and publicly available SWATH library generated by 
nanoLC-MS/MS26. Although generated using another chromatography regime, this library quantified 1256 ± 23 
Spectronaut 8.0 using a spectral library generated by yeast proteome prefractionation. (G) The coverage of the 
yeast proteome by microLC-based proteomics upon prefractionation. A yeast tryptic digest obtained from 
BY4741-pHLUM32 was first separated by high pH reverse phase chromatography on an analytical HPLC and 
then analyzed in DDA mode with m/z (gas phase) fractionation at 3 µL/min flow rate. In the sample exhaustion 
approach, the same digest was instead injected repeatedly until protein identification was saturated. When 
comparing the proteins identified in both approaches with the abundances of yeast proteins as measured by 
fluorescence microscopy21, the most abundant proteins were consistently identified, while proteins with low 
expression levels were only identified upon pre-fractionation. Inset: In total, 3822 (84%) or 1037 (23%) out of 
4517 expressed yeast proteins21 were identified using either microLC-SWATH method, respectively. (H) Peak 
representation in microLC-SWATH-MS. Extracted ion chromatogram (XIC) of the peptide TPVITGAPYYER 
recorded in microLC-SWATH mode using either 34 × 25 m/z or 29 × 16 m/z windows, respectively. A 
conventional (nanoLC-optimized) SWATH setting25 of 34 × 25 m/z with a cycling time of 3.3 s leads to a 
coverage of 5 points per peak. When limiting the mass range covered to 400–850 m/z which contains precursors 
for 96% of proteins, and reducing accumulation time to 40 ms, cycling time is 1.3 s to cover microLC 
chromatographic peaks by >11 data points, (I) Different strategies to construct SWATH spectral libraries and 
their application in microLC-SWATH-MS. A yeast tryptic digest was analyzed using microLC 
(0.3 mm × 250 mm Triart-C18, 3 µL/min, 60 min gradient) SWATH-MS by repeated (9×) injection of a tryptic 
digest derived from 10 µg yeast protein. Data was processed with Spectronaut 8.0 using SWATH libraries 
generated by either sample fractionation (frac), sample exhaustion (exh; matrix-matched library), using a 
spectral library recorded in an unrelated lab and instrument set-up (Biognosys library), or with a library 
generated by DIA-Umpire without physically recording a separate spectral library. Data analysis on the basis of 
the fractionation allowed quantification of 1766 proteins, the exhaustion library quantified 1271 proteins, the 
unrelated SWATH library 1256 proteins, and DIA-Umpire 952 proteins. DIA-Umpire yielded the lowest 
variability. (J) Human protein quantification using microLC-SWATH. A tryptic digest of a whole-cell protein 
extract from human K562 cells was analyzed using microLC (0.3 mm × 250 mm Triart-C18, 3 µL/min, 60 min 
gradient) and coupled to a TripleTOF5600 MS operating in SWATH mode by analysing 3 µg tryptic digest six 
times. Data was processed with Spectronaut 8.0 using a SWATH library obtained from the SWATHAtlas 
repository31 (10k library), or using SWATH libraries generated by repeated analysis of HEK293 or HeLa cell 
extracts (Spectronaut repository). Data extraction by using the rich library quantified 4169 K562 proteins, while 
2031 proteins when using a library generated from HEK293 cells, and 1906 using a HeLa library, respectively. 
(K) Precision of yeast protein quantification using microLC-SWATH-MS. Signal variability (expressed as fold 
change) of 677 proteins present in all datasets was compared throughout nine replicates. Median coefficients of 
variation are between 7.3% and 8% for libraries generated using respectively fractionation (frac) and exhaustion 
(exh) approach, 7.6% for an unrelated yeast library, and 5.4% for DIA-Umpire. (L) Technical variability of 
human protein quantification is low in microLC-SWATH-MS. Signal variability (expressed as fold-change) of 
726 proteins present in all datasets was compared throughout the six replicates. (M) Retention time stability 
microLC-SWATH-MS over 327 yeast whole-proteome acquisitions in three defined batches. Correlation 
between measured apex retention time and predicted retention time. Shown is a representative yeast sample 
acquired in SWATH mode. Inset: Mean retention time standard deviation of 6 iRT peptides across 327 
injections is 17.7 s. (N) Retention time stability in large sample series as measured by microLC-SWATH-MS. 
327 yeast tryptic digest samples spiked with iRT peptides were analyzed by microLC-SWATH-MS in three 
batches in a net acquisition time of 16 days (grey vertical lines). Retention times of iRT peptides are shown over 
time (colored lines), and retention time coefficient of variation for all peptides is lower than 2% over the whole 
period. Red vertical lines indicate the interspersed quality control samples (QC) sample measurements needed 
for batch correction. (O) Completeness of a large SWATH dataset is well represented with median Qvalue 
filtering. The number of proteins in a SWATH dataset of 1 to 327 yeast samples was determined with either 
sparse or complete Qvalue filtering, Qvalue percentile or Qvalue median filtering as implemented in 
Spectronaut software (coloured lines). The number of proteins was also determined when applying a 1% protein 
FDR filter (black line). (P) Quantification precision in large sample series as measured by microLC-
SWATH-MS. Coefficient of variation for fold changes of 8686 peptides was calculated in batch 1 (green), batch 2 
(orange), batch 3 (purple) or across batches (magenta) prior to batch correction. Intra-batch CVs were around 
12%, while variability over the entire 27 day period was 17.4%, as calculated from the repeated measurement of 
QC samples (as in (N)). (Q) The quantification of 327 yeast proteomes before batch correction. 38 yeast strains 
were grown in three batches, and each batch was acquired as three technical replicates in SWATH-MS together 
with 10–12 evenly distributed QC samples. In a PCA, proteomes cluster according to the acquisition batch, with 
color-coded technical replicates clustering together. (R) The quantification of 327 yeast proteomes after batch 
correction. After batch correction based on the combined quality control sample profiles, clustering according 
to batches is reduced, and proteomes cluster according to the color-coded yeast strain. Inset: Median coefficients 
of variation of peptide intensities between all 9 replicates of each strain are 39.7 ± 3.2 before batch correction 
and 22.3 ± 5.4 after batch correction.
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and 1118 ± 26 proteins on the microflow datasets, respectively. Without the need for a separately acquired spec-
tral library, on this sample DIA-Umpire quantified 952 ± 0 and 890 ± 2 proteins (Fig. 1I and Suppl. Fig. 3). Peptide 
quantification numbers followed similar trends (Suppl. Figs 4 and 5). In parallel, we tested the performance 
of microLC-SWATH-MS on a standardized whole-proteome human cell line (K562) tryptic digest, by extract-
ing data using three publicly available spectral libraries generated by combining multiple tissues and fractiona-
tion31 or by repetitive injection of tissue-specific cell digests of HEK293 or HeLa cells (Spectronaut26 repository). 
MicroLC-SWATH-MS achieved quantification of 3951 ± 205, 1832 ± 74 and 2007 ± 63 proteins, respectively, out 
of single-injections of the unfractionated K562 protein digest, with peptide numbers following the same trend 
(Fig. 1J, Suppl. Fig. 7).
The implementation of microLC-SWATH-MS yielded precise quantities for label free proteomics, both in 
small scale and large scale experiments. In small scale, the median coefficients of variation (CVs) for replicate 
injections of the yeast samples in all acquisition strategies and analysis libraries were 5.4–8.8% (Fig. 1K and Suppl. 
Fig. 6) and 5.5–7% for the human cell line (Fig. L) and Suppl. Fig. 8). The precision was largely similar over the 
full dynamic range spanning five orders of magnitude (Suppl. Figs 9 and 10). Interestingly, proteins identified 
by DIA-Umpire, which in our samples were lower in number compared to other approaches, yielded a higher 
precision in the quantification experiments (Fig. 1K). This could be related to a better signal-to-noise ratio of 
high abundant analytes, or to the highly abundant part of the proteome being generally more stable. Indeed, we 
also detect the abundance bias in the peptides identified by DIA-Umpire, indicating its the quantification of more 
abundant peptides that results in more precise values (Suppl. Fig. 11).
In order to determine the performance characteristics of microLC-SWATH-MS for the intended application 
of acquiring large numbers of proteomes for data driven biology, we conducted two large studies to optimize strat-
egies for retention time and batch correction, as well as peptide selection. In the first, we analyzed 296 proteomes 
of Saccharomyces cerevisiae strains in the BY4741-pHLUM background32. 38 yeast strains, each with a single gene 
deletion, were grown in nine replicates to exponential phase, sampled, and processed by a protocol using the 
Rapigest detergent (Waters, UK) as reported earlier33. Including quality control (QC) samples, this benchmark 
span over 327 whole-proteome samples, recorded in three batches upon coupling the QTOF mass spectrometer 
to a commercial nanoLC system (nanoAcquity, Waters) that had been converted to a microLC by exchanging 
capillaries of larger diameter. Even before applying retention time normalization, the converted nanoLC yielded 
highly stable retention times in microflow (standard deviation of apex retention times 17.7 s in 60 min gradients 
over the 327 runs, Fig. 1M, inset). This value was further improved using linear retention time normalisation 
using standard peptides20, upon which an excellent agreement with theoretically expected retention times was 
achieved (Fig. 1N). Furthermore, to address the batch effects that unavoidably confound quantitative proteomics 
when conducted in large scale34,35, we established a batch correction strategy that repetitively includes a mixture 
of a combined sample (QC control) every 10–12 injections. Then, we applied an empirical Bayes framework36,37 
to correct data for observed batch effects associated with acquisition dates by specifying covariates. Batches span-
ning 100 to 116 whole-proteome acquisitions were each acquired over a period of around 9 days (net acquisition 
time 6 days). Analysing the proteomes using the spectral library created by sample exhaustion and containing 
1323 proteins, yielded the typical quantification of 1212 ± 100 proteins in the average sample.
A typical problem of large-scale data analysis is that, ideally, it should yield the consistent quantification of a 
given analyte across all samples. Removing all precursors that have one or more values with >1% FDR in any of 
the 327 proteomes (complete filtering) reduces the number of proteins to 497. However, this procedure artificially 
reduces proteome depth, as it over-rates the FDR in one sample over the recurrence of a signal in hundreds of 
samples. Filtering with a Qvalue percentile of 10% is sufficient to increase the number of consistently quantified 
peptides by almost 50% (Fig. 1O). On the other hand, sparse filtering, i.e. retaining every precursor that has at 
least one value with >1% FDR, artificially inflates the dataset. In our hands, the best compromise was found when 
filtering by the median Qvalue, which gives both consistent results and retains a high number of quantified pro-
teins (Fig. 1O). Indeed, when also evaluating proteome depth by controlling protein FDR, we found that median 
Qvalue filtering is more conservative than controlling protein FDR38–40.
Finally, we evaluated the quantitative precision of our workflow, which is arguably an equal or even more 
important benchmark compared to peptide identification numbers for judging the quality of large scale pro-
teomics experiments produced for data-driven applications. For this, we determined coefficient of variation (CV) 
values for the obtained peptide quantities. The median CVs of the peptides quantified in QC sample (repeated 
injections over the whole experiment) were 12% within a batch, while 17.4% between batches (Fig. 1P). This 
characteristic equals, or even exceeds, precision values typically obtained in label and label-free proteomic exper-
iments, even when conducted in small scale25,41–43.
In order to also demonstrate the retention of the biological variability upon batch correction, we analysed 
the differences between the technical CVs and total CVs, which include both technical and biological variability. 
Our batch correction method reduced the total signal variability by 43%, which largely corresponds to the batch 
effect, while maintaining the specific individual strain’s proteome profile within the batch, as illustrated by the 
confidence boundary in a principal component analysis (Fig. 1Q,R, Suppl. Figs 12 and 13). Eventually, the aver-
age variation of peptides quantifying >1100 proteins across the 327 samples, is determined with a median CV of 
22.3 ± 5.4% (Fig. 1R, inset).
In parallel we tested the platform to see whether we can distinguish differences in proteomes of so called 
redundant biological signalling molecules by exploiting semi-targeted feature extractions from data-independent 
mass spectrometry data. For this benchmark, we selected all yeast strains deleted for a protein kinase that are via-
ble in minimal medium32. We measured their proteome by microLC-SWATH-MS in exponential growth phase, 
and extracted the quantities of 289 metabolic enzymes, as these constitute one of the largest functional class of 
proteins in the high-abundant fraction of the proteome. In order to yield precision on the enzymome dataset, 
we selected the peptides for quantification not by abundance, but by highest pairwise correlation. This strategy 
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assumes that all peptides that are derived from the same protein are suitable for quantification; this strategy 
excludes peptides that behave inconsistently across the measured samples, i.e. as they are differentially posttrans-
lationally modified. We used a correlation-dependent peptide selection strategy, as developed by us earlier in 
combination with an MSE workflow13. An analogous strategy is used in the mapDIA workflow, for example44. Then 
we optimized the batch correction strategy for the semi-targeted approach. We used parametric adjustment of the 
raw signals as in supervised surrogate variable (SVA) analysis37. SVA was applied without specifying experimental 
factors45, using 50% of least variable peptides as controls. Estimated surrogate effects were regressed out from the 
peptide signal. Finally, for each protein, the signals of all peptide groups were geometrically averaged. Following 
this semi-targeted strategy, 289 metabolic enzyme levels were quantified across 397 measured proteomes over 
a period of four months. The median quantitative precision (CV values) accessed from the QC samples that we 
injected over the duration of the experiment, was calculated to be 19%. Hence, microflow-SWATH-MS allows 
the precise semi-targeted quantification of large selected protein groups over hundreds of samples. A manuscript 
describing the biological meaning of enzyme abundance changes as measured in all viable yeast kinase knockout 
strains is submitted for publication elsewhere (Zelezniak et al., Submitted, Cell Systems, December 2017).
In conclusion, we show that microLC-based proteomics is able to achieve broad protein identification char-
acteristics. In combination with a microflow-optimized data independent acquisition workflow, a platform is 
obtained that can capture a quantitative snapshot of a yeast or human proteome in an hour or less, and at the same 
time maintain high quantitative precision that remains consistent over months and over hundreds of proteomes. 
The performance characteristics are illustrated by the untargeted and semi-targeted quantification of proteins in 
>750 yeast proteomes acquired. We yielded a quantitative performance, expressed as lower than 20% average 
CV across hundreds of samples recorded over a five month acquisition period. It is important to mention that 
due to a more exhaustive usage of the created tryptic digests, the workflow does not need more starting material 
compared to conventional (nanoLC) based proteomic workflows, and is economic by not being dependent on 
the latest instrument hardware and the use of microflow-columns that have longer run times compared to their 
nanoLC-counterpart, reducing both material costs as well as hands-on time, while increasing throughput. Broad 
access to large and precisely measured sample series is the foundation for data driven systems biology that enables 
application of machine learning approaches to uncover so far missed biological patterns46. It further empowers 
the analysis of large time-series and cohorts of comparative studies in basic and clinical research, e.g. to enable 
predictive diagnostics. Indeed, the high flow rate renders microLC-SWATH-MS a highly robust proteomic tech-
nology with low instrument downtime and maintenance cycles, increasing data quality simply through minimiz-
ing instrumental bias and leading to higher productivity and cost effectiveness.
Materials and Methods
Materials, solutions and reagents. Chemicals and reagents were obtained from Sigma, UPLC/MS grade 
chromatographic solvents from Greyhound, unless stated otherwise.
Sample preparation for mass spectrometry. A standardized yeast sample was generated by grow-
ing the prototrophic Saccharomyces cerevisiae strains YSBN147 or BY4741-pHLUM32 in Yeast Nitrogen Base 
(YNB) medium without amino acids containing 2% glucose until mid-exponential phase. Cells were harvested 
by centrifugation and snap-frozen in aliquots equaling 10 OD600 units. Sample preparation was performed as 
described33 with the following modifications. Cells were broken by bead shaking with 200 µL 0.05 M ammonium 
bicarbonate in a FastPrep instrument (3 × 30 s, 6.5 m/s, 4 °C), and cell pellet after centrifugation was re-extracted 
with 200 µL lysis buffer (0.1 M NaOH, 0.05 M EDTA, 2% SDS, 2% 2-mercaptoethanol) for 10 min at 90 °C, and 
again for 10 min at 90 °C after addition of 0.1 M acetic acid. Combined supernatants were precipitated using 10% 
TCA, and processed further according to the RapiGest protocol33. Protein concentration before digest was deter-
mined using Pierce BCA assay kit (Thermo), and adjusted to 2 µg/µL with 0.2% RapiGest SF (Waters) in ABC. MS 
compatible human protein digest from K562 cells was obtained from Promega.
For library generation using pre-fractionation, 1 mg of yeast tryptic digest was separated by high pH reverse 
phase chromatography on a Waters ACQUITY instrument. A reverse phase column (Waters, BEH C18, 
2.1 × 150 mm, 1.7 µm) was utilized in combination with a 20 mM ammonium formate to 20 mM ammonium 
formate/80% ACN gradient, collecting 33 fractions. Before analysis, samples were spiked with 0.5 × HRM kit 
(Biognosys). QC samples were prepared as a mixture of 10% of each individual sample.
Chromatography. Chromatographic separation was performed either on an Ekspert NanoLC 425 sys-
tem (Eksigent/SCIEX) for combined nano and micro flow analysis, or a nanoACQUITY system (Waters) for 
microflow-only sample series. In nano flow, the NanoLC 425 system was equipped with a nanolitre flow module, 
and samples were first loaded onto a trap column (Chrom XP C18–3µm, 0.12 nm, 0.35 × 0.5 mm) by isocrati-
cally running the system at a flow rate of 5 µL/min for 6 min with 0.1% formic acid (FA) in water. Peptides were 
then eluted onto the analytical column (3C18-CL-120, 3 µm, 0.12 nm, 0.075 × 150 mm, Eksigent) and separated 
on a linear gradient of 2–30% 0.1% FA in acetonitrile (ACN) in 25 min. For microlitre flow rate chromatog-
raphy, the same system was equipped with a low microlitre flow module (1–5 µL/min) or high microlitre flow 
module (5–10 µL/min) and set up for direct injection onto an analytical column (3C18-CL-120, 3 µm, 120 Å, 
0.3 × 150 mm, Eksigent). Separation was performed on a linear gradient of 2–30% 0.1% FA in ACN in 25 min. 
For microlitre flow rate chromatography on the nanoACQUITY system, the sample manager was set up in direct 
injection mode and equipped with a Triart C18 column (0.12 nm, 3 µm, 0.3 mm × 250 mm, YMC). After injecting 
samples onto the analytical column, peptides were separated on linear gradients detailed in Suppl. Table 2.
Mass Spectrometry. SWATH data was recorded on a Tandem Quadrupole Time-of-Flight mass spectrom-
eter (TripleTOF560019, SCIEX) coupled to either a Nanospray III Ion Source (SCIEX) or a DuoSpray Analytical 
www.nature.com/scientificreports/
8Scientific RepoRts |  (2018) 8:4346  | DOI:10.1038/s41598-018-22610-4
Ion Source (SCIEX), controlled by Analyst software (v.1.6). For nanoflow, the ion source was equipped with 
10 µm SilicaTip electrospray emitters (New Objective) and parameters were as described33. For microflow, the ion 
source was equipped with a 25 µm TurboIonSpray probe (SCIEX), and parameters were as follows: ISVF = 5500, 
GS1 = 10, GS2 = 0, CUR = 25, TEM = 100.
To acquire spectral libraries, the mass spectrometer was operated in information-dependent acquisition (IDA) 
and high sensitivity mode, with first a 250 ms TOF MS survey scan over a mass range of 400–1250 m/z, followed 
by 100 ms MS/MS scans of 20 ion candidates per cycle with dynamic background subtraction. The selection 
criteria for the parent ions included the intensity, where ions had to be greater than 150 cps, with a charge state 
between 2 and 4. The dynamic exclusion duration was set for 1 s. Collision-induced dissociation was triggered 
by rolling collision energy. For generation of SWATH libraries by sample fractionation, precursor-rich fractions 
were further injected twice, with online gas phase fractionation between the mass ranges of 400–650 m/z and 
650–1250 m/z. For data-independent acquisition, the instrument was operated in SWATH mode with selection 
windows detailed in Suppl. Table 3 for mass ranges of 400–1250 or 400–850 m/z. With accumulation times of 100 
and 40 ms cycle times were 3.3 s and 1.3 s, respectively.
Data analysis and SWATH library generation. All SWATH assay libraries generated in this study were 
built following the protocol by Schubert et al.27. Briefly, spectral data acquired in IDA mode was centroided 
using qtofpeakpicker48. Centroided files were searched with X! Tandem29 and Comet30 against the annotated yeast 
proteins database with included reversed decoy peptides. Search results were scored using PeptideProphet and 
combined with iProphet. Mayu40 was used to estimate iProphet probabilities to control for protein identification 
false discovery rate (FDR <1%). The final spectral library was assembled using SpectraST49 by retaining spectra 
above iProphet FDR controlled cutoff and normalizing chromatography to iRT peptide retention time reference. 
SpectraST output was then converted to tsv format suitable for Spectronaut retaining 6 most intense transitions 
of y and b ions using spectrast2tsv from msprotoemicstools50. For large-scale data analysis of 327 yeast samples, 
a minimal consensus library constructed from exhaustion-based IDA acquisitions was compiled in Spectronaut. 
In the DIA-Umpire approach, we extracted precursor-fragment features by applying signal extraction module 
from DIA-Umpire workflow using default recommended parameters for TripleTOF5600 instrument on data 
acquired in SWATH mode by sample exhaustion of the yeast proteome. Generated pseudo MS/MS.mgf files were 
converted into mzXML and further subjected to database search and processed as described above to generate 
SWATH assay library. All SWATH data quantification was performed in Spectronaut (v. 8.0.9600, Biognosys) 
using default settings. Publicly available SWATH libraries used were obtained from the Biognosys library repos-
itory or from SWATHAtlas31.
For visualization of chromatographic peaks, data of selected peptides was analyzed in Skyline51 (v. 3.5.0.9191) 
with SWATH isolation windows detailed in Suppl. Table 2, and chromatograms of precursors and products 
exported as text files. For calculation of peak capacities, IDA data was analyzed with QuiC (Biognosys).
Post-processing was conducted in R52 by first removing precursors from all samples where the median Qvalue 
was >0.01. Injection differences were corrected by a robust sum approach where the most and least intense 10% 
of peptide precursors are removed from the reference pool, and peptides belonging to the same protein were 
selected based on correlation criteria across all the samples13. To account for confounding effects related to acqui-
sition dates in large samples series, we performed batch correction by introducing QC samples in experimental 
design. External standard QC samples were prepared as a mixture of all injected samples and were measured 
every 10–12 samples. Each MS acquisition batch had >10 QC samples allowing to correct for the most evident 
batch effects attributed to an acquisition date (Suppl. Fig. 12). Signal correction was performed using ComBat 
approach36 by specifying covariates that includes QC samples and genotypes of measured mutants using para-
metric adjustments. Briefly, for every peak group, the signal was modeled as function of the peptide signal and 
additive and multiplicative batch effects that were estimated by an empirical Bayes framework36. The estimated 
batch effects were then subtracted from the observed signal to obtain a “clean” peptide signal. Finally, the signals 
of all peptide groups were geometrically averaged. ComBat routine was used as explained in the R sva package 
documentation37. Plotting was performed in ggplot2 package53.
Data availability statement. Supplementary Table 1 gives an overview over the generated datasets; they 
are further used as basis of a parallel manuscript submission (Zelezniak et al., submitted, Cell Systems, December 
2017) and enabled the prediction of metabolite concentrations by artificial intelligence. The datasets are being 
deposited in Pride (https://www.ebi.ac.uk/pride/archive/) and will be made available online upon publication of 
the manuscript.
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